Icon

Ovide - (0.5% Lotion; Topical)

Malathion Taro pharma
0.5% Lotion; Topical
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Used to treat head lice infections. It belongs to the group of medicines known as pediculicides (medicines that kill lice). Malathion acts by killing both the lice and their eggs.
Yes
****** (*****) ** ***. ****** ***** * **** ** *** *** *********. *****, ***** ***** * **** ** *** *** *********. ** ****** **** **** ***** ******* ** *** ****. ****, ********** ********* **** **** *********. ** *** **, ****, ***** ******** ******* ** **. *****, ******* ***** * **** ** *** *** *********. ** ****** **** **** ******** ****** ****** ** **** ****. ****, ********** ******* **** ******** ******, ***** ** *** ********** *****, ******** *** ****** **** ***** *** ****. *** *** *** **** ************.
Ovide Patent 1 Patent 2
****** ******* *******
***** ******* *******
******** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** **, **** ******* ******** ************ *********
***** ** \ ** *** **, **** ******* ******** ******** ** *** **, ****
******** ** \ ** **** **, **** ******* **** ****** **** ********
  1. *** **, **** : **** ****** ***** * **** ******* ****** ****** **** ****** '***
  2. *** **, **** : ********** ********* **** ****** ******
  3. ***** **, **** : ***** ******** **** ***** *** **** ** ****** **** ****** '***.
  4. ***** **, **** : **** ***** * **** ******* ***** ** ******** ***** ** **.
  5. *** **, **** : ********** *** ********* **** ***** *** ***** ** ********* *** *******.
  6. *** **, **** : ******** ****** **** ***** *** **** ** ************* **** ******* ******* (*** *, ****) & ******* (*** **, ****).
  7. *** **, **** : **** ***** * **** ******* ******** ** ** ** *** ******.
  8. *** **, **** : **** ****** ******* **** ******** ******, ***** ** *** ********** *****, ******** *** ****** **** ***** *** ****.
  9. *** **, **** : ****** ******** ******** **** ***** *** **** ** ****** *** * ******.
  10. *** **, **** : **** **** ****** ******** **** ******* ' *** *** '*** ******** ** **** **** *** **** ************.
  11. *** **, **** : **** *** ****** ******* ********** ** ******* *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.